首页> 外文期刊>Expert opinion on drug delivery >Molecularly imprinted therapeutic contact lenses.
【24h】

Molecularly imprinted therapeutic contact lenses.

机译:分子印迹治疗性隐形眼镜。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

IMPORTANCE OF THE FIELD: There exists a considerable unmet need for more efficacious delivery of ocular therapeutics. Contact lenses have been developed with high loading and controllable sustained release to overcome limited patient compliance and significant ocular transport limitations. This can best be achieved by extending and controlling the residence time of drugs on the eye surface and thereby limiting drug loss by lacrimation, drainage and non-productive absorption. AREAS COVERED IN THE REVIEW: Within hydrogels, molecular imprinting can be used to create memory for template molecules embedded within a flexible macromolecular network. Control in therapeutic loading and delay of release have been demonstrated with careful attention to the functional monomer/template ratio, the diversity of functional monomers, and the polymer backbone and network structure. Experimental work has also confirmed that macromolecular memory and not structural differences or phenomena are responsible for delayed drug release kinetics compared with non-imprinted systems. A therapeutically relevant amount of drug can be loaded for release to occur over multiple days, which allows the technique to be applied to daily-wear and extended-wear contact lenses. WHAT THE READER WILL GAIN: The focus of this article is to review the emerging field of molecularly imprinted contact lenses and highlight significant accomplishments, trends, as well as future strategies and directions. TAKE HOME MESSAGE: In the past 8 years, molecular imprinting has been used to produce therapeutic contact lenses with enhanced loading and delayed release. Progress in the field has mostly included low-molecular-weight therapeutics such as anti-glaucoma, antihistamine, antibiotic and anti-inflammatory therapeutics used to treat anterior eye disorders. Recently, high molecular weight comfort molecules have also been successfully demonstrated. Current methods can produce lenses of suitable thickness, water content, and mechanical and optical properties compared with commercial lenses on the market today.
机译:领域的重要性:对于眼药的更有效递送存在相当大的未满足的需求。已经开发出具有高负荷和可控的持续释放的隐形眼镜,以克服有限的患者依从性和明显的眼部运输限制。这可以通过延长和控制药物在眼表上的停留时间并通过流泪,引流和非生产性吸收来限制药物流失来最好地实现。综述中涉及的领域:在水凝胶中,分子印迹可用于为嵌入柔性大分子网络中的模板分子创建记忆。已经证明了对治疗负荷和释放延迟的控制,其中要特别注意功能性单体/模板比,功能性单体的多样性以及聚合物主链和网络结构。实验工作还证实,与非印迹系统相比,大分子记忆而非结构差异或现象是造成药物释放动力学延迟的原因。可以加载治疗上相关量的药物,以释放数日之久,从而使该技术可以应用于日常和长期佩戴的隐形眼镜。读者将获得什么:本文的重点是回顾分子印迹隐形眼镜的新兴领域,并强调重要的成就,趋势以及未来的策略和方向。寄语:在过去的8年中,分子印迹技术已被用于生产负荷增加且释放延迟的治疗性隐形眼镜。该领域的进展主要包括低分子量疗法,例如用于治疗眼前部疾病的抗青光眼,抗组胺药,抗生素和抗炎疗法。近来,高分子量舒适分子也已被成功证明。与当今市场上的商用镜片相比,当前的方法可以生产出具有合适厚度,含水量以及机械和光学性能的镜片。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号